REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Clinicalbiotec S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Clinicalbiotec S.A. Profile Updated: April 07, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Clinicalbiotec S.A. is a company based in Ecuador, with its head office in Ibarra. It operates in the General Medical and Surgical Hospitals industry. The company was established on September 16, 2015. Clinicalbiotec S.A. currently employs 5 (2021) people. The latest financial highlights indicate a net sales revenue increase of 59.59% in 2022. Its’ total assets recorded a growth of 100.18%. The net profit margin of Clinicalbiotec S.A. increased by 83.51% in 2022.

Headquarters
Calle 10 de Diciembre Cs 02 Pb Chillanes Conj 02
Ibarra; Imbabura;

Contact Details: Purchase the Clinicalbiotec S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Clinicalbiotec S.A. report to view the information.
Outstanding Shares:
Purchase the Clinicalbiotec S.A. report to view the information.
Registered Capital:
Purchase the Clinicalbiotec S.A. report to view the information.
Incorporation Date:
September 16, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Clinicalbiotec S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
59.59%▲
Total operating revenue
59.59%▲
Operating profit (EBIT)
1649.26%▲
EBITDA
925.59%▲
Net Profit (Loss) for the Period
1647.44%▲
Total assets
100.18%▲
Total equity
N/A
Operating Profit Margin (ROS)
84.03%▲
Net Profit Margin
83.51%▲
Return on Equity (ROE)
N/A
Quick Ratio
11.99%▲
Cash Ratio
10.65%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo